Mainz Biomed(MYNZ) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

MYNZ Mainz Biomed

Watchlist

4.365
-0.365-7.72%

Close Mar 14 16:00 ET

4.350
-0.015-0.34%

Post 20:01 ET

9.70MMarket Cap-0.10P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Mainz Biomed, Liquid Biosciences Make Discovery of MRNA Biomarkers
TipRanksMar 13 08:15 ET
Mainz Biomed Enters Agreement With Liquid Biosciences To Develop Blood Test For Pancreatic Cancer Detection
BenzingaMar 13 08:08 ET
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of MRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Mainz BiomedMar 13 00:00 ET
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift From Screening to Prevention
Mainz BiomedMar 3 00:00 ET
Mainz Biomed Partners With Labor Team W Ag to Launch ColoAlert Colorectal Cancer Screening Test in Switzerland
Quiver QuantitativeFeb 20 08:13 ET
Mainz Biomed Expands Into Switzerland With Labor Team W
Mainz BiomedFeb 20 00:00 ET

Comments

Jaguar8

Mar 14 06:30

🟡Watchlist, MARCH 14,2025, Friday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

Teddy123

Mar 13 20:12

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

$Mainz Biomed (MYNZ.US)$
Revolutionary mRNA Blood Test Detects Pancreatic Cancer with Near-Perfect Accuracy

Trytosaveabit

Mar 13 20:05

News

$Mainz Biomed (MYNZ.US)$ Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
2 MINUTES AGO, 8:01 AM EDT
VIA GLOBENEWSWIRE
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood Samples
Mainz Biomed Enters into Exclusive Licensing Agreement for the Portfolio of mRNA Biomarkers, with Continued Development of Machine Learning AI-Based ...

Jaguar8

Mar 13 20:03

NEWS

$Mainz Biomed (MYNZ.US)$
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Thursday, 13th March at 8:01 am
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood Samples
Mainz Biomed Enters into Exclusive Licensing Agreement for the Portfolio of mRNA Biomarkers, with Continued Development of Machine Learning AI-Based Algorithm Bas...